(HealthDay)—For patients with head and neck cancer, a multidisciplinary head and neck clinic model is associated with reduced treatment delay, according to a study published online Oct. 26 in JAMA Otolaryngology—Head ...
Oct 29, 2017
0
1
(HealthDay)—For organ recipients in Norway, the risk of skin cancer, particularly squamous cell carcinoma (SCC), has decreased since the mid-1980s, according to a study published online Oct. 18 in JAMA Dermatology.
Oct 20, 2017
0
1
There's a framed picture in Dr. Terrence Hopkins' waiting room at his Manatee Dermatology practice that shows a little girl in a bikini on a beach with a jarring combination of words printed next to it.
Sep 11, 2017
0
2
Nivolumab (trade name: Opdivo) has been approved since June 2017 for adults with squamous cell carcinoma of the head and neck. The drug is an option if platinum-based chemotherapy is not sufficiently effective against this ...
Sep 6, 2017
0
0
(HealthDay)—Alcohol intake seems to be positively associated with basal cell carcinoma (BCC) and cutaneous squamous cell carcinoma (cSCC), according to a review and meta-analysis published online July 28 in the British ...
Jul 31, 2017
0
1
(HealthDay)—High intake of total and saturated fat is associated with increased risk of lung cancer, according to research published online July 25 in the Journal of Clinical Oncology.
Jul 28, 2017
0
1
(HealthDay)—A type of skin cancer called squamous cell carcinoma (SCC) is increasingly common in the United States, so people need to be alert for signs of the disease, an expert says.
Jul 27, 2017
0
0
(HealthDay)—Of a sample of lesions deemed seborrheic keratoses clinically, 3.1 percent were histologically diagnosed as malignancies, according to research published online June 7 in the Journal of Cutaneous Pathology.
Jun 15, 2017
0
0
(HealthDay)—Survivors of squamous cell carcinoma of the anus (SCCA) have an elevated risk of human papillomavirus (HPV)-related second primary malignancies (SPMs), according to a study published online June 13 in Cancer.
Jun 15, 2017
0
0
PD-L2 protein expression in human tumors was associated with clinical response to pembrolizumab (Keytruda), an anti-PD-1 immunotherapy, independent of PD-L1 expression, in patients with head and neck squamous cell carcinoma ...
Jun 15, 2017
0
0
